Tuberculosis innovations mean little if they cannot save lives

DSpace/Manakin Repository

Tuberculosis innovations mean little if they cannot save lives

Citable link to this page

 

 
Title: Tuberculosis innovations mean little if they cannot save lives
Author: Pai, Madhukar; Furin, Jennifer

Note: Order does not necessarily reflect citation order of authors.

Citation: Pai, Madhukar, and Jennifer Furin. 2017. “Tuberculosis innovations mean little if they cannot save lives.” eLife 6 (1): e25956. doi:10.7554/eLife.25956. http://dx.doi.org/10.7554/eLife.25956.
Full Text & Related Files:
Abstract: The past decade has seen the emergence of new diagnostics and drugs for tuberculosis, a disease that kills over 1.8 million people each year. However, these new tools are yet to reach scale, and access remains a major challenge for patients in low and middle income countries. Urgent action is needed if we are committed to ending the TB epidemic. This means raising the level of ambition, embracing innovation, increasing financial investments, addressing implementation gaps, and ensuring that new technologies reach those who need them to survive. Otherwise, the promise of innovative technologies will never be realized. DOI: http://dx.doi.org/10.7554/eLife.25956.001
Published Version: doi:10.7554/eLife.25956
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5413344/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:33029767
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters